Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy

Area of Science:

• Epigenetics
• Nephrology
• Molecular Biology

Background:

• Diabetic complications, including nephropathy, are linked to histone deacetylase (HDAC)-mediated epigenetic changes.
• Current HDAC inhibitors lack specificity, targeting multiple HDACs with diverse functions.
• Developing specific HDAC inhibitors requires understanding the role of individual HDACs in diabetic nephropathy.

Purpose of the Study:

• To investigate the role of specific histone deacetylases (HDACs) in diabetic nephropathy.
• To determine the expression patterns of HDACs in diabetic kidney conditions.
• To elucidate the specific contribution of HDAC4 to podocyte injury and renal damage.

Main Methods:

• Analysis of HDAC expression in kidney tissues from diabetic animal models and human biopsies.
• In vitro studies using podocytes exposed to high glucose, advanced glycation end products, and TGF-β.
• In vivo gene silencing of HDAC4 using intrarenal lentiviral delivery in diabetic rats.
• Investigation of the HDAC4-STAT1 signaling pathway and its effect on autophagy and inflammation.

Main Results:

• HDAC2, HDAC4, and HDAC5 were upregulated in the kidneys of diabetic rats, diabetic mice, and human diabetic patients.
• High glucose, AGEs, and TGF-β selectively increased HDAC4 expression in podocytes.
• In vivo silencing of HDAC4 reduced renal injury in diabetic rats.
• HDAC4 promoted podocyte injury by suppressing autophagy and enhancing inflammation via the HDAC4-STAT1 pathway.

Conclusions:

• HDAC4 is significantly upregulated in diabetic nephropathy and directly contributes to podocyte injury.
• HDAC4 plays a critical role in the signaling pathway linking renal injury to autophagy.
• Targeting HDAC4 represents a potential strategy for developing specific therapies for diabetic nephropathy.